Clinical trial
Tranexamic Acid After Pathological Fracture Treated With Modular Arthroplasty: Retrospective Observational Study
NCT06244498 is registered in ClinicalTrials.gov with Piotr Biega as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tranexamic Acid After Pathological Fracture Treated With Modular Arthroplasty: Retrospective Observational Study
- Lead sponsor
- Piotr Biega
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2018
- Completion date
- December 31, 2022
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metastases to bone